Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barrett

Showing results (611-620 of 752) with videos related to

Pageof 76
Sort By:
Diabetes|February 28, 2003
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndromeGerald F Watts, P Hugh R Barrett, Juying Ji, et al.
Clinical Endocrinology|June 22, 2010
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapyB G A Stuckey, P H R Barrett, J M Wagner, et al.
Lipids|March 15, 2018
Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal WomenStefania Lamon-Fava, Margaret R Diffenderfer, P Hugh R Barrett, et al.
Metabolism: Clinical and Experimental|March 16, 2016
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)Margaret R Diffenderfer, Stefania Lamon-Fava, Santica M Marcovina, et al.
Obesity Research|June 25, 2005
High-density lipoprotein apolipoprotein A-I kinetics in obesityEsther M M Ooi, Gerald F Watts, Maryam S Farvid, et al.
Leukemia|May 29, 2010
Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CMLE Weisberg, X Deng, H G Choi, et al.
European Journal of Clinical Investigation|August 22, 2006
High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studiesE M M Ooi, G F Watts, M S Farvid, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugsTimothy M E Davis, Juliana Hamzah, Kenneth F Ilett, et al.
Journal of Neuroscience Methods|January 7, 2004
Design and application of a novel brain slice system that permits independent electrophysiological recordings from multiple slicesM Stopps, N Allen, R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal statusNirupa R Matthan, Susan M Jalbert, Stefania Lamon-Fava, et al.
Pageof 76

Showing results (611-620 of 752) with videos related to

Sort By:
Pageof 76
Diabetes|February 28, 2003
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndromeGerald F Watts, P Hugh R Barrett, Juying Ji, et al.
Clinical Endocrinology|June 22, 2010
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapyB G A Stuckey, P H R Barrett, J M Wagner, et al.
Lipids|March 15, 2018
Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal WomenStefania Lamon-Fava, Margaret R Diffenderfer, P Hugh R Barrett, et al.
Metabolism: Clinical and Experimental|March 16, 2016
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)Margaret R Diffenderfer, Stefania Lamon-Fava, Santica M Marcovina, et al.
Obesity Research|June 25, 2005
High-density lipoprotein apolipoprotein A-I kinetics in obesityEsther M M Ooi, Gerald F Watts, Maryam S Farvid, et al.
Leukemia|May 29, 2010
Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CMLE Weisberg, X Deng, H G Choi, et al.
European Journal of Clinical Investigation|August 22, 2006
High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studiesE M M Ooi, G F Watts, M S Farvid, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugsTimothy M E Davis, Juliana Hamzah, Kenneth F Ilett, et al.
Journal of Neuroscience Methods|January 7, 2004
Design and application of a novel brain slice system that permits independent electrophysiological recordings from multiple slicesM Stopps, N Allen, R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 4, 2005
TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal statusNirupa R Matthan, Susan M Jalbert, Stefania Lamon-Fava, et al.
Pageof 76